Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Brukinsa
Descriptions
Zanubrutinib is used to treat mantle cell lymphoma (MCL) in adults who have received at least one previous treatment for their cancer. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Zanubrutinib is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2020
Copyright © 2020 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.